BioWorld

Feb. 14, 2003

View Archived Issues

Epimmune Plans Acquisition Of Anosys For Synergistic Platform

The San Diego-based company entered a preliminary merger agreement with Anosys Inc. to create a combined entity focused on immunotherapeutics and products to treat cancer and infectious diseases. (BioWorld Today) Read More

RAC Says Stopping Trials With Retroviral Vectors Not Warranted

Read More

Trans-Atlantic Genomic Search For Leprosy Susceptibility Gene Heats Up Over Chromosomal Candidates

Read More

Albany Molecular Expands Via Lilly Deal, Organichem Purchase

Read More

Holiday Notice

Read More

Correction

Read More

Other News To Note

Read More